Nusinersen in infants who initiate treatment in a presymptomatic stage of spinal muscular atrophy (SMA): Interim results from the phase 2 nurture study

被引:0
|
作者
Ryan, M. M. [1 ,2 ,3 ]
De Vivo, D. C. [4 ,5 ]
Bertini, E. [6 ]
Hwu, W. L. [7 ,8 ]
Crawford, T. O. [9 ]
Swoboda, K. J. [10 ]
Finkel, R. S. [11 ]
Kirschner, J. [12 ]
Kuntz, N. L. [13 ]
Parsons, J. [14 ]
Butterfield, R. J. [15 ]
Topaloglu, H. [16 ]
Ben Omran, T. [17 ,18 ,19 ]
Sansone, V. A. [20 ,21 ]
Jong, Y. J. [22 ]
Shu, F. [23 ]
Foster, R. [24 ]
Bhan, I. [25 ]
Fradette, S. [26 ]
Farwell, W. [26 ]
机构
[1] Royal Childrens Hosp, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Murdoch Childrens Res Inst, Dept Neurol, Melbourne, Vic, Australia
[4] Columbia Univ, Irving Med Ctr, Dept Neurol, New York, NY USA
[5] Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY 10027 USA
[6] Postgrad Bambino Gesu Childrens Res Hosp, Unit Neuromuscular & Neurodegenerat Disorders, Rome, Italy
[7] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan
[8] Natl Taiwan Univ Hosp, Dept Pediat, Taipei, Taiwan
[9] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[10] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA
[11] Nemours Childrens Hosp, Dept Pediat, Orlando, FL USA
[12] Univ Hosp Bonn, Dept Neuropediat, Bonn, Germany
[13] Ann & Robert H Lurie Childrens Hosp Chicago, Div Neurol, Chicago, IL 60611 USA
[14] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA
[15] Univ Utah, Dept Pediat & Neurol, Salt Lake City, UT USA
[16] Hacettepe Univ, Dept Pediat Neurol, Ankara, Turkey
[17] Sidra Med Qatar Fdn, Dept Pediat, Doha, Qatar
[18] Hamad Med Corp, Div Clin & Metab Genet, Doha, Qatar
[19] Hamad Med Corp, Dept Pediat, Doha, Qatar
[20] Univ Milan, Neuromuscular Omniserv, Milan, Italy
[21] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy
[22] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan
[23] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA
[24] Biogen, Biostat, Maidenhead, Berks, England
[25] Biogen, Drug Safety, Cambridge, MA USA
[26] Biogen, Clin Dev, Cambridge, MA USA
关键词
D O I
10.1016/j.jns.2019.10.1276
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
WCN19-1058
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Nusinersen in Infants Who Initiate Treatment in a Presymptomatic Stage of Spinal Muscular Atrophy (SMA): Interim Results From the Phase 2 NURTURE Study
    Finkel, Richard S.
    De Vivo, Darryl C.
    Swoboda, Kathryn J.
    Bertini, Enrico
    Hwu, Wuh-Liang
    Foster, Richard
    Bhan, Ishir
    Fradette, Stephanie
    Farwell, Wildon
    [J]. NEUROLOGY, 2020, 94 (15)
  • [2] Nusinersen in infants who initiate treatment in a presymptomatic stage of Spinal Muscular Atrophy (SMA): interim results from the phase 2 NURTURE study
    Sansone, V. A.
    De Vivo, D. C.
    Bertini, E.
    Hwu, W. -L.
    Crawford, T. O.
    Swoboda, K. J.
    Finkel, R. S.
    Kirschner, J.
    Kuntz, N.
    Parsons, J.
    Ryan, M. M.
    Butterfield, R. J.
    Topaloglu, H.
    Ben Omran, T.
    Jong, Y. -J.
    Shu, F.
    Bevernage, S. P.
    Johnson, K.
    Foster, R.
    Bhan, I.
    Fradette, S.
    Farwell, W.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 83 - 83
  • [3] Nusinersen in Infants who Initiate Treatment in a Presymptomatic Stage of Spinal Muscular Atrophy: Interim Results from the Phase 2 NURTURE Study
    Butterfield, R.
    De Vivo, D.
    Bertini, E.
    Hwu, W-L
    Crawford, T.
    Swoboda, K.
    Finkel, R.
    Kirschner, J.
    Kuntz, N.
    Parsons, J.
    Ryan, M.
    Topaloglu, H.
    Ben Omran, T.
    Sansone, V
    Jong, Y-J
    Shu, F.
    Johnson, K.
    Foster, R.
    Bhan, I
    Fradette, S.
    Farwell, W.
    [J]. ANNALS OF NEUROLOGY, 2019, 86 : S117 - S117
  • [4] Nusinersen in infants who initiate treatment in a presymptomatic stage of spinal muscular atrophy: interim results from the phase 2 NURTURE study
    Ryan, M.
    De Vivo, D.
    Bertini, E.
    Hwu, W.
    Crawford, T.
    Swoboda, K.
    Finkel, R.
    Kirschner, J.
    Kuntz, N.
    Parsons, J.
    Butterfield, R.
    Topaloglu, H.
    Ben Omran, T.
    Sansone, V.
    Jong, Y.
    Shu, F.
    Foster, R.
    Bhan, I.
    Fradette, S.
    Farwell, W.
    [J]. NEUROMUSCULAR DISORDERS, 2019, 29 : S185 - S185
  • [5] Nusinersen in Infants Who Initiate Treatment in a Presymptomatic Stage of Spinal Muscular Atrophy (SMA): Interim Efficacy and Safety Results From the Phase 2 NURTURE Study
    Crawford, T.
    De Vivo, D.
    Bertini, E.
    Hwu, W. L.
    Foster, R.
    Bhan, I
    Farwell, W.
    Reyna, S.
    [J]. ANNALS OF NEUROLOGY, 2018, 84 : S392 - S392
  • [6] Nusinersen in Infants Who Initiatte Treatment in a Presymptomatic Stage of Spinal Muscular Atrophy (SMA): Interim Efficacy and Safety Results From the Phase 2 NURTURE Study
    De Vivo, Darryl C.
    Topaloglu, Haluk
    Swoboda, Kathryn J.
    Bertini, Enrico
    Hwu, Wuh-Liang
    Crawford, Thomas O.
    Foster, Richard
    Bhan, Ishir
    Fradette, Stephanie
    Farwell, Wildon
    Reyna, Sandra P.
    [J]. NEUROLOGY, 2019, 92 (15)
  • [7] Nusinersen effect in infants who initiate treatment in a presymptomatic stage of SMA: NURTURE results
    Crawford, T.
    Ryan, M.
    Kirschner, J.
    Finkel, R.
    Swoboda, K.
    De Vivo, D.
    Bertini, E.
    Hwu, W.
    Foster, R.
    Ramirez-Schrempp, D.
    Chin, R.
    Farwell, W.
    [J]. NEUROMUSCULAR DISORDERS, 2020, 30 : S125 - S125
  • [8] Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
    De Vivo, Darryl C.
    Bertini, Enrico
    Swoboda, Kathryn J.
    Hwu, Wuh-Liang
    Crawford, Thomas O.
    Finkel, Richard S.
    Kirschner, Janbernd
    Kuntz, Nancy L.
    Parsons, Julie A.
    Ryan, Monique M.
    Butterfield, Russell J.
    Topaloglu, Haluk
    Ben-Omran, Tawfeg
    Sansone, Valeria A.
    Jong, Yuh-Jyh
    Shu, Francy
    Staropoli, John F.
    Kerr, Douglas
    Sandrock, Alfred W.
    Stebbins, Christopher
    Petrillo, Marco
    Braley, Gabriel
    Johnson, Kristina
    Foster, Richard
    Gheuens, Sarah
    Bhan, Ishir
    Reyna, Sandra P.
    Fradette, Stephanie
    Farwell, Wildon
    [J]. NEUROMUSCULAR DISORDERS, 2019, 29 (11) : 842 - 856
  • [9] Interim Efficacy and Safety Results from the Phase 2 NURTURE Study Evaluating Nusinersen in Presymptomatic Infants with Spinal Muscular Atrophy
    De Vivo, Darryl C.
    Hwu, Wuh-Liang
    Reyna, Sandra P.
    Farwell, Wildon
    Gheuens, Sarah
    Sun, Peng
    Zhong, Zhenshao John
    Su, John
    Schneider, Eugene
    Bertini, Enrico
    [J]. NEUROLOGY, 2017, 88
  • [10] One-year Outcomes Following Treatment with Nusinersen: Interim Results from the NURTURE Study of Presymptomatic Infants with Genetically Diagnosed Spinal Muscular Atrophy (SMA)
    De Vivo, D.
    Bertini, E.
    Hwu, W-L
    Foster, R.
    Gheuens, S.
    Farwell, W.
    Reyna, S.
    [J]. ANNALS OF NEUROLOGY, 2017, 82 : S265 - S266